To further explore how EZH2 is involved in glioma pathogenesis, we performed GSEA between tissues with different EZH2 expression levels and found that EZH2 expression was associated with essential signalling pathways, including cell cycle, DNA replication, mismatch repair, p53 signalling and pyrimidine metabolism. The gene discussed is EZH2; the disease is central nervous system cancer.